Pulmonary embolism is a common and potentially fatal cardiovascular disorder that must be
promptly diagnosed and treated. The diagnosis, risk assessment, and management of …

D-dimer is a soluble fibrin degradation product deriving from the plasmin-mediated
degradation of cross-linked fibrin. D-dimer can hence be considered a biomarker of …

D-dimer containing species are soluble fibrin degradation products derived from plasmin-
mediated degradation of cross-linked fibrin, ie,'D-dimer'. D-dimer can hence be considered a …

Venous thromboembolism is a common disease which remains underdiagnosed because of
nonspecific presentations which can range from asymptomatic incidental imaging findings to …

Background The diagnosis of pulmonary embolism (PE) in pregnant women represents an
ongoing challenge. As in the general population, the first step in pregnant women with …

Background In patients with suspected pulmonary embolism (PE) and a non‐high pretest
probability, the use of an age‐adjusted D‐dimer cutoff (AADD,< 500 ng/mL up to 50 years …

D-dimer is a multifaceted biomarker of concomitant activation of coagulation and fibrinolysis,
which is routinely used for ruling out pulmonary embolism (PE) and/or deep vein thrombosis …

Background Pulmonary embolism (PE) is the third most common cardiovascular syndrome
with an average annual incidence rate of 77 per 100,000 population in the worldwide. The …

An accurate and prompt diagnosis of deep vein thrombosis and/or pulmonary embolism is
important to prevent serious complications and mortality. Because the clinical presentation …

Pulmonary Embolism (PE) is a life-threatening condition initiated by the presence of blood
clots in the pulmonary arteries, leading to severe morbidity and mortality. Underlying …